Better in theory than in practise? Challenges when applying the luck egalitarian ethos in health care policy.


Journal

Medicine, health care, and philosophy
ISSN: 1572-8633
Titre abrégé: Med Health Care Philos
Pays: Netherlands
ID NLM: 9815900

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 23 6 2020
medline: 5 8 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Luck egalitarianism, a theory of distributive justice, holds that inequalities which arise due to individuals' imprudent choices must not, as a matter of justice, be neutralized. This article deals with the possible application of luck egalitarianism to the area of health care. It seeks to investigate whether the ethos of luck egalitarianism can be operationalized to the point of informing health care policy without straying from its own ideals. In the transition from theory to practise, luck egalitarianism encounters several difficulties. We argue that the charge of moral arbitrariness can, at least in part, be countered by our provided definition of "imprudent actions" in the health area. We discuss the choice for luck egalitarianism in health care between ex ante and ex post policy approaches, and show how both approaches are flawed by luck egalitarianism's own standards. We also examine the problem of threshold setting when luck egalitarianism is set to practise in health care. We argue that wherever policy thresholds are set, luck egalitarianism in health care risks pampering the imprudent, abandoning the prudent or, at worst, both. Furthermore, we claim that moves to mitigate these risks in turn diminish the normative importance of the ethos of luck egalitarianism to policy. All in all, our conclusion is that luck egalitarianism cannot be consistently applied as a convincing and relevant normative principle in health care policy.

Identifiants

pubmed: 32566983
doi: 10.1007/s11019-020-09962-3
pii: 10.1007/s11019-020-09962-3
pmc: PMC7538444
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

735-742

Références

Camb Q Healthc Ethics. 2018 Jan;27(1):87-92
pubmed: 29214964
J Occup Health. 2016 May 25;58(2):216-9
pubmed: 27010081
Clin Chest Med. 2011 Dec;32(4):605-44
pubmed: 22054876
J Med Ethics. 2015 Oct;41(10):836-40
pubmed: 26269464
J Med Ethics. 2005 Aug;31(8):476-80
pubmed: 16076974
Ethics Int Aff. 2002;16(2):47-55
pubmed: 15709278
J Med Ethics. 2019 Oct;45(10):636-644
pubmed: 31221764
Bioethics. 2008 Feb;22(2):77-83
pubmed: 18251767
J Appl Philos. 1999;16(3):255-69
pubmed: 15497230
J Med Ethics. 2010 Nov;36(11):661-5
pubmed: 20817816

Auteurs

Joar Björk (J)

Stockholm Centre for Healthcare Ethics (CHE), LIME, Karolinska Institutet, Tomtebodavägen 18 A, 171 77, Stockholm, Sweden. joar.bjork@ki.se.
Department of Research and Development, Region Kronoberg, PO Box 1223, 351 12, Växjö, Sweden. joar.bjork@ki.se.

Gert Helgesson (G)

Stockholm Centre for Healthcare Ethics (CHE), LIME, Karolinska Institutet, Tomtebodavägen 18 A, 171 77, Stockholm, Sweden.

Niklas Juth (N)

Stockholm Centre for Healthcare Ethics (CHE), LIME, Karolinska Institutet, Tomtebodavägen 18 A, 171 77, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH